Ignite Creation Date:
2024-05-05 @ 5:25 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00440232
Status:
COMPLETED
Last Update Posted:
2011-05-26
First Post:
2007-02-22
Brief Title:
A Research Study To Evaluate If Frovatriptan Is Safe And Effective In Preventing Migraine Headache After Fasting
Sponsor:
Thomas Jefferson University
Organization:
Thomas Jefferson University
Study Overview
Official Title:
A Pilot Trial Examining the Safety and Efficacy of Frovatriptan as a Preemptive Treatment for Fasting-Induced Migraine Headache
Status:
COMPLETED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
We are testing the hypothesis that subjects in the treatment group will experience fewer fasting induced headaches as compared to those in the placebo groupIn our clinical experience we estimate that approximately 25 of our headache population experiences fasting-induced migraine or hunger-induced migraine With a given migraine incidence of 28 million in the United States alone we estimate that approximately 7 million will experience hunger as a migraine trigger If an individual has a known migraine trigger then there are a variety of ways to modify care in order to address that trigger The simplest is to avoid that trigger or preemptively treat that trigger Frovatriptan has good evidence for daily use for a short time to help prevent menstrually related migraines A short course of treatment can often avoid the initiation of the migraine and improve quality of life Knowing that a longer acting triptan such as frovatriptan has demonstrated capability at suppressing headache through a known trigger suggests the need to study this with fasting induced migraines as well
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None